Atomi Financial Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.59M Buy
28,242
+5,807
+26% +$508K 0.07% 214
2026
Q1
$1.91M Buy
22,435
+1,507
+7% +$134K 0.06% 257
2025
Q4
$1.65M Buy
20,928
+13,409
+178% +$1.05M 0.05% 267
2025
Q3
$601K Sell
7,519
-323
-4% -$27.6K 0.02% 571
2025
Q2
$713K Buy
7,842
+985
+14% +$89.9K 0.03% 449
2025
Q1
$642K Buy
6,857
+368
+6% +$33K 0.03% 432
2024
Q4
$590K Buy
6,489
+394
+6% +$37.6K 0.03% 421
2024
Q3
$633K Buy
6,095
+692
+13% +$70.5K 0.04% 369
2024
Q2
$524K Buy
5,403
+888
+20% +$81.9K 0.04% 381
2024
Q1
$407K Buy
4,515
+1,162
+35% +$98.5K 0.04% 418
2023
Q4
$267K Buy
+3,353
New +$252K 0.04% 452

Other funds holding CL

Atomi Financial Group's CL Position: Q2 2026 in Review

Atomi Financial Group increased its Colgate-Palmolive (CL) stake by 26% in Q2 2026, buying an estimated $508K and bringing the position to 28,242 shares worth $2.59M. The position accounts for 0.07% of the portfolio, ranked #214.

Atomi Financial Group first reported a position in CL in Q4 2023 and has held it in 11 quarters since. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Atomi Financial Group held 28,242 shares of Colgate-Palmolive worth $2.59M as of Q2 2026.
  • Atomi Financial Group bought 5,807 Colgate-Palmolive shares in Q2 2026, an estimated $508K.
  • Colgate-Palmolive made up 0.07% of Atomi Financial Group's portfolio in Q2 2026, its #214 holding.
  • Atomi Financial Group first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.